carlo
silvestreroig
zvi
g
fridlend
michael
glogauer
patrizia
scapini
new
evid
challeng
outdat
dogma
neutrophil
homogen
popul
shortliv
cell
although
neutrophil
subpopul
distinct
function
report
homeostat
patholog
condit
full
understand
neutrophil
heterogen
plastic
current
lack
review
current
knowledg
neutrophil
heterogen
divers
highlight
need
deep
genom
phenotyp
function
profil
identifi
neutrophil
subpopul
determin
whether
cell
truli
repres
bona
fide
novel
neutrophil
subset
suggest
progress
understand
neutrophil
heterogen
allow
identif
clinic
relev
neutrophil
subpopul
may
use
diagnosi
specif
diseas
lead
develop
new
therapeut
approach
neutrophil
thought
consist
homogen
popul
cell
display
potent
antimicrobi
function
includ
phagocytosi
degranul
neutrophil
extracellular
trap
net
see
glossari
product
data
past
decad
reveal
neutrophil
may
also
exert
immunoregulatori
function
well
display
phenotyp
function
plastic
heterogen
popul
circul
neutrophil
describ
base
discret
paramet
eg
cellsurfac
marker
buoyanc
matur
function
local
healthi
patholog
condit
includ
cancer
infect
autoimmun
inflammatori
disord
addit
number
studi
describ
exist
tissuebas
popul
neutrophil
either
resid
newli
infiltr
acquir
special
phenotypesfunct
depend
tissu
microenviron
continu
grow
question
neutrophil
heterogen
signific
interest
howev
consensu
criteria
andor
molecular
evid
demonstr
unequivoc
reproduc
defin
clinic
relev
distinct
neutrophil
subset
therefor
whether
variou
report
neutrophil
popul
consist
bona
fide
neutrophil
subset
repres
differ
state
matur
andor
activ
neutrophil
expos
diseasespecif
patholog
condit
remain
main
open
question
field
review
summar
critic
discuss
recent
find
mammalian
neutrophil
heterogen
view
sever
speciesspecif
differ
might
profound
impact
phenotyp
function
plastic
neutrophil
human
mous
studi
separ
discuss
highlight
similar
differ
current
find
two
speci
emerg
evid
heterogen
popul
neutrophil
organ
rhesu
macaqu
zebrafish
hors
beyond
scope
discuss
human
sever
public
report
healthi
individu
circul
neutrophil
variabl
express
reflect
control
epigenet
mechan
figur
also
known
human
neutrophil
antigen
glycoprotein
neutrophil
primari
respond
infect
tissu
damag
grow
bodi
evid
suggest
distinct
subpopul
cell
immunoregulatori
associ
cancer
inflammatori
diseas
sourc
neutrophil
subpopul
remain
open
question
unclear
deriv
differenti
bone
marrow
ii
gener
either
via
activ
matur
immatur
neutrophil
chang
destin
tissu
develop
fieldwid
univers
accept
neutrophil
function
marker
well
reproduc
simplifi
isol
protocol
may
allow
standard
approach
studi
neutrophil
subpopul
although
difficult
achiev
may
acceler
consolid
understand
challeng
field
glossari
ancaassoci
system
vascul
autoimmun
diseas
affect
small
blood
vessel
bodi
caus
anca
deposit
angiogenesi
new
blood
vessel
format
preexist
vasculatur
antigenpres
cell
apc
heterogen
group
immun
cell
process
present
antigen
recognit
cell
antineutrophil
cytoplasm
antibodi
anca
group
autoantibodi
antigen
present
cytoplasm
neutrophil
granulocyt
arginas
enzym
deplet
larginin
local
environ
thu
caus
cell
suppress
lselectin
cell
adhes
molecul
found
predomin
leukocyt
chronic
granulomat
diseas
inherit
disord
phagocyt
lose
abil
produc
ro
decidua
endometrium
pregnant
uteru
epigenom
studi
epigenomerevers
herit
chromatin
chang
affect
gene
express
without
alter
dna
sequenc
emerg
granulopoiesi
de
novo
gener
granulocyt
respons
system
inflamm
infect
granulopoiesi
de
novo
gener
blood
granulocyt
homeostat
condit
immun
toler
state
unrespons
immun
system
lipopolysaccharid
lp
major
compon
outer
membran
gramneg
bacteria
function
import
activ
innat
immun
lowdens
neutrophil
popul
neutrophil
within
mononuclear
cell
fraction
obtain
blood
densiti
gradient
centrifug
margin
zone
mz
region
interfac
red
white
pulp
exampl
spleen
commit
myeloid
precursor
subsequ
differenti
stage
defin
immatur
neutrophil
differenti
segment
matur
neutrophil
rest
condit
termin
differenti
neutrophil
releas
circul
recov
normaldens
neutrophil
ndn
box
current
evid
suggest
differ
neutrophil
subpopul
defin
indic
marker
present
human
blood
homeostat
condit
rest
condit
neutrophil
also
margin
pool
within
lung
spleen
liver
phenotyp
function
cell
remain
poorli
defin
uniqu
popul
human
neutrophil
found
margin
zone
mz
spleen
term
b
cell
helper
neutrophil
n
bh
cell
owe
robust
b
cellactiv
properti
mice
mous
neutrophil
develop
within
bm
compris
three
trend
immunolog
express
plasma
membran
within
specif
granul
neutrophil
known
promot
interact
neutrophil
endotheli
cell
well
transmigr
vasculatur
bind
platelet
endotheli
cell
adhes
integrin
also
serv
receptor
membranebound
proteinas
major
antigen
target
antineutrophil
cytoplasm
antibodi
anca
associ
express
suscept
develop
anca
associ
system
vascul
investig
similarli
neutrophil
popul
small
proport
circul
matur
neutrophil
healthi
subject
express
glycoprotein
olfactomedin
contain
within
specif
neutrophil
granul
figur
specif
function
protein
neutrophil
still
unknown
inde
whether
neutrophil
repres
real
distinct
function
popul
remain
unclear
neutrophil
display
major
function
differ
differenti
abil
produc
net
vitro
notabl
frequenc
neutrophil
increas
sepsi
rel
healthi
condit
wherea
frequenc
circul
neutrophil
increas
inflammatori
diseas
includ
asthma
sepsi
cancer
inflammatori
bowel
diseas
import
note
although
presenc
subpopul
report
sever
studi
deeper
understand
specif
function
cell
necessari
determin
prognost
therapeut
clinic
valu
studi
suggest
base
differenti
express
select
marker
circul
neutrophil
subpopul
exampl
express
cell
receptor
proangiogen
vascular
endotheli
growth
factor
present
healthi
individu
observ
remain
valid
neutrophil
ontogeni
current
recogn
major
contributor
heterogen
rapid
homeostat
turnov
size
circul
matur
neutrophil
pool
maintain
fine
balanc
granulopoiesi
neutrophil
releas
bone
marrow
bm
circul
ultim
return
bm
final
clearanc
resid
macrophag
figur
although
latter
process
better
character
mice
see
also
evid
neutrophil
recycl
destruct
within
human
bm
current
renew
interest
better
understand
sequenti
step
neutrophil
matur
well
transcriptom
epigenom
program
carri
granulocyt
progress
acquir
specif
function
abil
complic
understand
neutrophil
ident
phenotyp
circul
matur
neutrophil
appear
vari
cours
lifespan
similarli
consist
publish
paper
util
mous
model
see
diurnal
oscil
cxc
chemokin
receptor
type
express
found
circul
neutrophil
healthi
subject
propos
correl
neutrophil
matur
age
moreov
shown
flow
cytometri
analysi
perform
differ
time
day
proport
young
age
neutrophil
popul
among
circul
neutrophil
healthi
individu
shown
regul
circadian
oscil
figur
tissu
tradit
consid
devoid
neutrophil
absenc
inflammatori
insult
howev
recent
find
mice
see
reveal
neutrophil
decondens
dna
embed
protein
nuclear
cytoplasm
granul
origin
neutrophil
ontogeni
origin
develop
matur
neutrophil
normaldens
neutrophil
ndn
popul
neutrophil
found
within
granulocyt
fraction
top
red
cell
blood
densiti
gradient
centrifug
pentraxin
solubl
pattern
recognit
receptor
select
pathogen
function
innat
immun
program
death
ligand
immunoinhibitori
molecul
suppress
cell
activ
reactiv
oxygen
speci
ro
reactiv
molecul
free
radic
deriv
molecular
oxygen
rheumatoid
arthriti
ra
chronic
autoimmun
disord
primarili
affect
joint
stem
cell
mobil
process
wherebi
stem
cell
mobil
bone
marrow
enter
bloodstream
system
lupu
erythematosu
sle
chronic
autoimmun
diseas
caus
inflamm
joint
skin
organ
helper
th
cell
type
cell
provid
help
cell
immun
respons
recogn
foreign
antigen
secret
cytokin
tolllik
receptor
tlr
receptor
recogn
structur
conserv
molecul
deriv
microb
transcriptom
studi
transcriptometh
complet
set
rna
produc
given
cell
distinct
subpopul
name
preneu
prolif
neutrophil
precursor
immatur
matur
neutrophil
observ
human
base
differenti
surfac
marker
express
circul
mous
neutrophil
exhibit
heterogen
associ
distinct
effector
activ
mice
human
neutrophil
margin
spleen
liver
lung
vasculatur
also
transit
resid
organ
muscl
skin
lymph
node
intestin
mous
spleen
three
neutrophil
subpopul
local
red
pulp
mz
particip
emerg
granulopoiesi
int
pneumococc
clearanc
high
regul
antibodi
product
mz
b
cell
nb
h
observ
human
exist
neutrophil
pool
homeostat
condit
resid
spleen
liver
addit
bm
context
although
find
remain
controversi
human
splenic
neutrophil
subpopul
resid
within
splenic
margin
zone
mz
defin
b
cell
helper
neutrophil
nb
h
cell
base
uniqu
abil
promot
b
cell
prolifer
antibodi
product
absent
rest
circul
neutrophil
figur
overal
research
necessari
gain
better
understand
phenotyp
function
featur
report
neutrophil
subpopul
circul
tissu
healthi
individu
express
surfac
glycoprotein
human
thought
defin
distinct
neutrophil
subpopul
also
present
mice
differ
proport
figur
howev
function
relev
remain
unknown
note
mous
neutrophil
subpopul
defin
proangiogen
describ
elsewher
development
analysi
neutrophil
popul
within
mous
bm
instead
reveal
exist
subpopul
prolif
precursor
well
immatur
matur
neutrophil
similar
circul
counterpart
also
propos
present
human
see
figur
subpopul
display
differ
expans
effector
activ
microbi
tumor
stress
inde
although
matur
neutrophil
found
essenti
antimicrobi
host
defens
mous
model
cecal
ligat
punctur
clp
induc
sepsi
neutrophil
precursor
abl
expand
support
granulopoiesi
clp
well
pancreat
melanoma
tumor
mous
model
latter
model
neutrophil
precursor
could
also
promot
tumor
growth
exert
cellmedi
immunosuppress
via
program
death
ligand
depend
mechan
similarli
neutrophil
age
process
better
document
mice
human
mobil
bm
circul
age
neutrophil
upregul
lose
home
back
bm
spleen
liver
clearanc
figur
age
neutrophil
also
retain
lung
becom
apoptot
interact
b
cell
process
preced
clearanc
tissueresid
macrophag
mous
model
b
cell
deplet
reduc
apoptosi
age
neutrophil
accumul
lung
induc
interstiti
inflamm
fibrosi
note
age
process
necessari
circadian
control
hematopoiet
nich
function
progenitor
mobil
also
enhanc
neutrophil
antimicrobi
activ
host
defens
mous
model
candida
albican
infect
thu
neutrophil
age
favor
migrat
tissu
nighttim
enhanc
antimicrobi
properti
neutrophil
time
day
mice
expos
pathogen
mechanist
antibiot
treatment
mice
defici
tolllik
receptor
tlr
show
reduc
number
age
neutrophil
rel
control
suggest
microbiom
signal
transduc
tlr
could
promot
neutrophil
age
moreov
owe
increas
inflammatori
activ
accumul
age
neutrophil
also
report
promot
vascular
damag
diseas
instanc
rel
control
contribut
increas
infarct
size
lesion
vasoocclus
mous
model
myocardi
infarct
sickl
cell
diseas
respect
final
shown
multipl
mous
studi
strong
evid
absenc
inflammatori
insult
neutrophil
necessarili
confin
bm
blood
margin
site
mostli
lung
spleen
abl
transit
remain
mani
tissu
might
exert
organspecif
function
figur
perhap
consist
special
macrophag
resid
liver
brain
ie
kupffer
cell
microglia
reason
specul
may
also
special
resid
neutrophil
within
tissu
site
although
remain
investig
regard
function
intestin
macrophagemedi
neutrophil
phagocytosi
shown
reduc
product
interleukin
il
lower
secret
granulocyt
colonystimul
factor
gcsf
thu
distal
control
granulopoiesi
within
bm
lung
neutrophil
infiltr
could
alter
circadian
regul
gene
transcript
well
suscept
develop
metastasi
tumor
mous
model
note
mass
cytometri
analysi
multipl
tissu
shown
myeloid
subset
neutrophil
display
highest
degre
heterogen
support
concept
special
neutrophil
present
within
differ
organ
instanc
line
observ
human
sampl
splenic
mzresid
neutrophil
constitut
subpopul
harbor
specif
abil
regul
b
cell
respons
mostli
via
secret
solubl
pentraxin
homeostasi
well
streptococcu
pneumonia
infect
figur
moreov
base
capac
motil
well
express
lymphocyt
antigen
complex
locu
specif
marker
mous
neutrophil
two
neutrophil
subpopul
identifi
within
splenic
red
pulp
subset
specif
role
mediat
pneumococc
clearanc
emerg
granulopoiesi
figur
highlight
fact
neutrophil
heterogen
also
found
within
specif
region
organ
line
concept
recent
studi
shown
heterogen
migratori
respons
bm
neutrophil
within
differ
bone
stroke
promin
recruit
neutrophil
calvaria
bone
compar
tibial
bone
collect
observ
suggest
sitespecif
differ
neutrophil
subpopul
phenotypeseven
within
specif
organ
relev
organ
anatom
special
region
spleen
howev
evid
valid
find
requir
human
recent
studi
report
immunosuppress
neutrophil
popul
display
heterogen
phenotyp
matur
activ
immatur
cell
might
play
role
fetomatern
immun
toler
prevent
patholog
condit
neonat
immunosuppress
lowdens
neutrophil
ldn
also
known
polymorphonuclear
myeloidderiv
suppressor
cell
pmnmdsc
box
describ
blood
neonat
well
blood
placenta
breast
milk
pregnant
women
effici
suppress
cell
prolifer
vitro
mostli
via
reactiv
oxygen
speci
ro
product
reveal
specif
function
assay
vitro
ldnspmnmdsc
neonat
pregnant
women
also
skew
type
helper
th
cell
balanc
toward
regulatori
cell
polar
phenotyp
also
inhibit
natur
killer
cell
cytotox
tlrexpress
monocyt
agreement
propos
role
neutrophil
angiogenesi
addit
neutrophil
popul
beyond
ldnspmnmdsc
describ
secondtrimest
decidua
popul
display
special
proangiogen
function
reveal
enhanc
abil
perform
transendotheli
invas
induc
endotheli
tube
format
vitro
compar
rest
circul
neutrophil
consid
immun
toler
angiogenesi
fundament
process
pregnanc
cancer
deeper
character
similar
differ
term
ontogeni
phenotyp
function
variou
neutrophil
popul
may
provid
better
understand
specificand
current
elusivediffer
mechan
protect
mammalian
fetus
immun
attack
altern
differ
angl
hijack
potenti
licens
tumor
develop
recent
evid
mous
model
corrobor
concept
similarli
human
suppress
neutrophil
popul
may
play
import
role
immun
toler
pregnanc
inde
mous
pmnmdscsthat
deem
immunosuppress
immatur
neutrophilshav
describ
anim
model
acut
chronic
inflamm
ie
trend
immunolog
cancer
infecti
diseas
autoimmun
obes
box
section
neutrophil
divers
heterogen
cancer
mous
pregnanc
increas
circul
pregnant
femal
rel
nonpregn
femal
migrat
uteru
drive
cell
suppress
thu
permit
embryo
implant
success
pregnanc
inde
deplet
neutrophil
use
antibodi
caus
cell
infiltr
uteru
resorpt
conceiv
embryo
mechanist
cell
suppress
pmnmdsc
report
driven
downregul
lselectin
box
circul
human
lowdens
neutrophil
gener
featur
matur
neutrophil
found
top
red
blood
cell
densiti
gradient
centrifug
blood
healthi
donor
refer
normaldens
neutrophil
ndn
altern
call
highdens
neutrophil
hdn
figur
contrast
densiti
gradient
centrifug
blood
patient
acut
chronic
inflammatori
diseas
reveal
heterogen
popul
neutrophil
within
mononuclear
cell
fraction
defin
lowdens
neutrophil
ldn
may
includ
immatur
matur
cell
latter
usual
display
featur
activateddegranul
neutrophil
although
decreas
buoyant
densiti
repres
intrins
featur
immatur
neutrophil
known
fraction
matur
neutrophil
becom
ldn
upon
vivo
activ
nonspecif
combin
marker
util
character
phenotyp
ldn
flow
cytometri
eg
lineag
marker
matur
marker
activ
marker
togeth
limit
number
studi
care
perform
phenotyp
function
comparison
ldn
autolog
ndn
hamper
definit
determin
whether
neutrophil
popul
relat
furthermor
ndn
healthi
donor
may
becom
ldn
consequ
improp
blood
handl
cell
isol
techniqu
comparison
variou
studi
may
problemat
highlight
need
care
follow
recent
establish
experiment
guidanc
character
isol
ldn
anoth
fundament
issu
studi
ldn
mostli
perform
isol
total
cell
thu
lead
function
result
distinguish
specif
contribut
matur
versu
immatur
neutrophil
major
popul
ldn
describ
date
includ
immunosuppress
ldn
also
known
polymorphonuclear
myeloidderiv
suppressor
cell
pmnmdsc
typic
found
cancer
pregnanc
infect
system
inflamm
see
main
text
ii
proinflammatori
ldn
lowdens
granulocyt
ldg
typic
found
autoimmun
diseas
see
main
text
crucial
issu
regard
ldn
owe
lack
standard
function
marker
definit
cell
immunosuppress
proinflammatori
deriv
test
activ
function
assay
perform
isol
cell
vitro
context
commonli
accept
requir
field
inde
definit
identifi
ldn
popul
pmnmdsc
must
reli
demonstr
abil
suppress
cell
respons
prolifer
andor
product
requir
valid
suppress
neutrophil
popul
describ
see
main
text
current
guidanc
standard
harmon
function
test
suppress
cell
recent
provid
ii
proinflammatori
lowdens
granulocyt
ldg
whether
autolog
normaldens
neutrophil
ndn
diseas
individu
also
display
either
proor
antiinflammatori
properti
remain
poorli
defin
trend
immunolog
cell
pregnant
femal
rel
nonpregn
femal
therebi
decreas
neutrophil
migrat
lymph
node
activ
mous
neonat
hint
put
mechan
pmnmdsc
differenti
stem
human
studi
show
breast
milkderiv
lactoferrin
could
stimul
pmnmdsc
product
immunosuppress
turn
deem
control
inflammatori
respons
associ
microbi
colon
gut
lung
infant
inde
deplet
pmnmdsc
exacerb
inflamm
reduc
surviv
experiment
mous
model
necrot
enterocolitisa
type
intestin
injuri
occur
microbiota
colon
infant
affect
human
newborn
although
latter
find
requir
valid
human
data
suggest
tolerogen
role
pmnmdsc
pregnanc
extend
first
week
life
control
inflamm
microbi
colon
neonat
human
mobil
immatur
neutrophil
circul
known
left
shift
wellcharacter
phenomenon
take
place
consequ
emerg
granulopoiesi
either
artifici
induc
eg
lipopolysaccharid
lp
gcsf
administr
diseaseassoci
eg
sepsi
infect
cancer
renew
interest
immatur
neutrophil
come
recent
evid
show
cell
despit
immatur
state
perform
innat
immun
function
eg
chemotaxi
antimicrobi
defens
well
display
function
plastic
immunoregulatori
properti
eg
modul
prolifer
cytokin
product
cell
whether
immatur
neutrophil
repres
distinct
neutrophil
subpopul
remain
open
question
differ
terminolog
use
describ
granulocyt
polymorphonuclear
pmn
cell
cancer
term
pmn
myeloidderiv
suppressor
cell
pmnmdsc
origin
refer
immatur
immunosuppress
granulocyt
mdsc
gener
term
assign
later
matur
immatur
myeloid
cell
either
monocyt
mmdsc
granulocyt
pmnmdsc
cell
capabl
suppress
immun
respons
exampl
cell
prolifer
subpopul
mdsc
possess
differ
immunosuppress
properti
mechan
howev
signific
phenotyp
function
overlap
pmnmdsc
neutrophil
make
hard
clearli
separ
two
mani
research
field
regard
pmnmdsc
distinct
popul
cell
howev
mani
other
believ
pmnmdsc
uniqu
separ
cell
popul
instead
subgroup
neutrophil
suppress
activ
moreov
current
see
phenotyp
path
distinguish
tan
pmnmdsc
tumor
inde
current
valid
marker
unequivoc
separ
pmnmdsc
neutrophil
box
main
text
instanc
mous
neutrophil
defin
cell
mous
pmnmdsc
also
defin
although
suppress
activ
human
matur
neutrophil
defin
human
pmnmdsc
defin
complex
phenotyp
panel
contain
least
six
marker
name
hladr
howev
could
also
describ
regular
neutrophil
inde
suggest
term
pmnmdsclike
describ
cell
surfac
marker
pmnmdsc
suppress
activ
accept
field
similar
phenotyp
definit
probabl
basi
confus
character
overlap
pmnmdsc
neutrophil
mice
human
base
recent
find
human
distinct
two
popul
base
matur
stage
conclus
wherea
pmnmdsc
initi
report
immatur
ie
part
immatur
ldn
recent
evid
suggest
least
set
matur
neutrophil
actual
immunosuppress
immatur
neutrophil
whether
mice
pmnmdsc
may
also
consist
matur
cell
remain
defin
clearli
seen
review
neutrophil
extrem
adapt
dynam
cell
capabl
mani
differentand
occasion
oppositefunct
simultan
thu
import
overlook
realiti
avoid
focus
singl
function
aspect
subpopul
neutrophil
ignor
parallel
function
system
inflamm
may
also
lead
gener
neutrophil
subpopul
endow
immunosuppress
properti
cell
empir
found
within
mononuclear
cell
fraction
abovement
ldnspmnmdsc
within
mononuclear
cell
normaldens
neutrophil
ndn
fraction
repres
neutrophil
obtain
via
red
blood
cell
lysi
without
perform
densiti
gradient
centrifug
figur
box
latter
two
type
usual
defin
suppress
neutrophil
unlik
ldnspmnmdsc
often
contain
immatur
element
homogen
compos
popul
matur
activ
cell
figur
box
typic
ldnspmnmdsc
observ
septic
patient
well
fungal
eg
aspergillu
fumigatu
c
albican
viral
eg
bunyaviru
hepat
c
b
viru
infect
shown
inhibit
prolifer
interferon
product
cell
vitro
via
ro
arginas
product
howev
phenotyp
function
less
well
character
ldnspmnmdsc
pregnanc
cancer
nonsuppress
ldn
display
either
proinflammatori
far
undefin
function
also
describ
patient
thrombocytopenia
syndrom
exhibit
sever
fever
well
patient
malaria
tuberculosi
asthma
popul
matur
activ
suppress
neutrophil
inhibit
cell
function
via
mechan
neutrophil
inhibit
cell
function
via
releas
report
ldn
ndn
peripher
blood
fraction
patient
well
healthi
donor
receiv
per
day
gcsf
day
stem
cell
mobil
gcsftreat
donor
respect
rel
healthi
control
figur
studi
perform
healthi
volunt
receiv
singl
system
administr
ngkg
lp
patient
trauma
induc
sever
injuri
popul
matur
activ
low
high
suppress
neutrophil
isol
directli
whole
blood
shown
display
hyperseg
nuclei
indic
increas
matur
compar
normal
blood
neutrophil
figur
cell
found
inhibit
prolifer
cytokin
eg
interleukin
il
product
cell
vitro
via
ro
releas
notabl
similar
popul
low
high
neutrophil
report
peripher
blood
nasal
biopsi
nasal
lavag
fluid
allerg
patient
well
peripher
blood
bronchoalveolar
lavag
fluid
infant
differ
type
viral
respiratori
infect
eg
respiratori
syncyti
viru
bocavirus
coronaviru
rhinovirus
without
bacteri
coinfect
eg
haemophilu
influenza
staphylococcu
aureu
streptococcu
pneumonia
pseudomona
aeruginosa
howev
former
case
allergi
low
high
neutrophil
display
cell
prime
activityrev
abil
increas
express
cell
latter
case
viral
infect
low
high
neutrophil
defin
immunosuppress
without
verifi
abil
inhibit
cell
function
vitro
overal
although
subpopul
human
neutrophil
endow
suppress
properti
propos
differ
pathophysiolog
condit
eg
pregnanc
acut
inflamm
infect
cancer
box
section
neutrophil
divers
heterogen
cancer
knowledg
cell
remain
limit
note
variou
studi
put
suppress
neutrophil
subpopul
identifi
util
typic
neutrophil
lineag
matur
andor
activ
marker
relev
may
uniqu
associ
immunosuppress
function
therefor
immunosuppress
properti
still
need
verifi
function
assay
perform
isol
cell
vitro
box
thu
deeper
understand
intrins
featur
neutrophil
subpopul
eg
transcriptom
phenotyp
properti
mechan
differenti
necessari
better
determin
whether
bona
fide
distinct
neutrophil
subset
deriv
common
progenitor
commit
trend
trend
immunolog
immunolog
figur
neutrophil
popul
infectionsinflamm
human
densiti
gradient
centrifug
blood
patient
acut
chronic
inflammatori
condit
includ
sepsi
infect
lead
detect
heterogen
popul
lowdens
neutrophil
ldn
within
mononuclear
cell
fraction
addit
normaldens
neutrophil
ndn
box
depend
studi
heterogen
ldn
shown
display
immunosuppress
propertiesterm
ldnspolymorphonuclear
myeloidderiv
suppressor
cell
pmnmdsc
wherea
ldn
shown
display
either
proinflammatori
far
undefin
function
addit
popul
matur
activ
suppress
neutrophil
present
ldn
ndn
fraction
obtain
red
blood
cell
lysi
without
perform
densiti
gradient
centrifug
mice
observ
human
pathogen
infect
differ
type
may
induc
appear
immatur
pmnmdsc
immunosuppress
function
circul
ldnspmnmdsc
infect
tissu
pmnmdsc
staphylococcu
aureu
candida
albican
model
infect
two
subpopul
neutrophil
opposit
function
proinflammatori
antiinflammatori
identifi
neutrophil
antigenpres
activ
apclik
neutrophil
gener
infect
encount
pathogen
tissu
subpopul
high
low
cxc
chemokin
receptor
type
low
neutrophil
migrat
lymph
node
promot
adapt
immun
popul
apclik
neutrophildc
hybrid
also
identifi
differ
mous
model
infect
moreov
infect
steril
injuri
neutrophil
retrotransmigr
affect
tissu
bloodstream
exert
deleteri
action
secondari
organ
also
exhibit
enhanc
abil
fight
pathogen
abbrevi
apc
antigenpres
cell
dc
dendrit
cell
suppress
function
altern
result
induc
state
maturationactiv
perhap
upon
sens
specif
chang
microenviron
subsequ
acquir
suppress
function
popul
neutrophil
identifi
inflammatoryinfecti
condit
includ
neutrophil
identifi
airway
cystic
fibrosi
patient
neutrophil
increas
sepsi
system
infect
eg
pneumonia
neutrophil
express
receptor
activ
nuclear
factor
ligand
rankl
member
tumor
necrosi
factor
tnf
superfamilyidentifi
blood
chronic
obstruct
pulmonari
diseas
patient
cysteinyl
leukotrien
receptor
neutrophil
present
nasal
lavag
fluid
patient
respiratori
tract
infect
caus
differ
virus
eg
influenza
viru
respiratori
syncyti
viru
rhinoviru
human
leukocyt
antigen
dr
isotyp
hladr
neutrophil
present
brazilian
patient
leishmaniasi
paraand
proinflammatori
neutrophil
popul
present
oral
caviti
healthi
chronic
periodont
diseas
subject
respect
question
remain
whether
popul
distinct
subset
deriv
differenti
via
activ
cytokin
present
ongo
diseaseinflammatori
process
studi
perform
use
mous
model
inflammationinfect
contribut
understand
neutrophil
heterogen
influenc
natur
sever
insult
pathogenan
import
concept
requir
investig
human
extens
review
elsewher
pioneer
paper
shown
differ
subpopul
neutrophil
develop
proinflammatori
antiinflammatori
case
methicillinresist
aureu
infect
figur
recent
mous
model
acut
infect
japanes
enceph
viru
chronic
infect
myobacterium
tuberculosi
polymicrobi
sepsi
popul
pmnmdsc
shown
inhibit
cell
prolifer
product
also
reduc
differenti
product
follicular
helper
cell
turn
support
pathogen
immun
evas
figur
moreov
pathogen
dose
also
decis
host
defens
induc
neutrophil
harbor
opposit
function
although
lethal
infect
francisella
tularensi
shown
induc
immatur
pmnmdsc
expans
bm
spleen
promot
tissu
damag
reduc
host
surviv
nonleth
dose
favor
expans
matur
neutrophil
lead
instead
resolut
infect
mous
model
clp
rel
control
activ
neutrophil
prevent
recruit
infect
peritoneum
via
downregul
chemokin
expressiona
process
associ
enhanc
mortal
sepsi
counter
administr
similarli
bacteri
product
shown
prime
neutrophil
activ
state
character
shed
surfac
enhanc
express
line
evid
neutrophil
activ
bacteri
infect
report
lead
subpopul
high
low
low
neutrophil
migrat
lymph
node
initi
adapt
respons
migrat
neutrophil
character
enhanc
express
surfac
receptor
associ
antigenpres
cell
apc
function
ie
mhc
class
ii
rel
circul
neutrophil
figur
similarli
popul
neutrophildendrit
cell
dc
hybrid
express
marker
neutrophil
dc
display
apc
activ
identifi
mice
acut
periton
escherichia
coli
chronic
skin
inflamm
fungal
infect
blastomyc
dermatitidi
fumigatu
c
albican
figur
note
similar
popul
neutrophildc
hybrid
isol
patient
lung
cancer
see
final
abil
neutrophil
retrotransmigr
bloodstream
migrat
lung
upregul
return
bm
clearanc
repres
addit
phenomenon
could
contribut
neutrophil
heterogen
infectioninflamm
mice
although
poorli
character
human
moreov
retrotransmigr
neutrophil
express
associ
secondari
organ
damag
well
effect
bacteri
phagocytosi
sepsi
figur
overal
although
specif
neutrophil
subpopul
found
mous
model
complet
mirror
human
counterpart
ie
cellsurfac
marker
import
similar
share
term
function
ie
immunosuppress
activ
apc
function
well
influenc
outcom
infect
result
mous
model
invalu
shed
light
import
specif
pathogen
infect
possibl
sourc
neutrophil
heterogen
inform
might
turn
help
develop
tailor
therapeut
strategi
improv
host
immun
defens
human
knowledg
neutrophil
heterogen
chronic
inflamm
deriv
studi
perform
autoimmun
diseas
studi
presenc
ldn
consist
report
patient
system
lupu
erythematosu
sle
psoriasi
chronic
granulomat
diseas
ancaassoci
system
vascul
rheumatoid
arthriti
ra
juvenil
idiopath
arthriti
pyogen
arthritispyoderma
gangrenosumacn
syndrom
oppos
immunosuppress
ldnspmnmdsc
ldn
autoimmun
patient
defin
lowdens
granulocyt
ldg
box
figur
base
proinflammatori
properti
includ
promot
cell
differenti
prolifer
import
note
distinct
ldnsldg
ldnspmnmdsc
base
function
assay
perform
isol
cell
valid
marker
identifi
discrimin
suppress
proinflam
immatur
matur
neutrophil
immatur
matur
proinflammatori
neutrophil
ndn
trend
trend
immunolog
immunolog
howev
studi
ldn
defin
pmnmdsc
without
test
inhibitori
action
cell
function
even
report
suppress
furthermor
whether
degre
circul
normaldens
neutrophil
ndn
cancer
patient
also
display
suppress
properti
remain
poorli
defin
depend
studi
human
tumorassoci
neutrophil
tan
report
either
promot
inhibit
cell
function
popul
human
leukocyt
antigen
dr
isotyp
hladr
antigenpres
cell
apc
like
hybrid
tan
trend
immunolog
matori
neutrophil
subpopul
box
describ
proinflammatori
function
ldg
includ
enhanc
abil
releas
proinflammatori
cytokin
includ
increas
abil
induc
endotheli
cell
toxic
vitro
compar
autolog
ndn
howev
gene
express
studi
attribut
ldn
ldg
perform
use
cell
isol
mononuclear
cell
declar
puriti
contamin
neutrophil
even
mononuclear
cell
may
lead
fals
posit
result
report
abil
proinflammatori
ldnsldg
produc
requir
confirm
use
truli
pure
sampl
nonetheless
main
pathogen
role
ldnsldg
autoimmun
appear
larg
relat
enhanc
abil
rel
autolog
ndn
expos
autoantigen
releas
net
context
net
releas
ldnsldg
obtain
peripher
blood
sle
patient
contain
compar
net
autolog
healthi
control
circul
ndn
elev
amount
immunogen
antigen
oxid
mitochondri
dna
citrullin
ubiquitin
antigen
activ
plasmacytoid
dendrit
cell
macrophag
moreov
ra
patient
netderiv
citrullin
antigen
circul
neutrophil
recent
found
phagocytos
present
vitro
gener
antigenspecif
cell
clone
synovi
fibroblast
turn
trigger
gener
autoantibodi
contribut
inflamm
howev
degre
proinflammatori
properti
eg
netosi
ldnsldg
specif
cell
remain
determinedespeci
consid
enhanc
product
andor
netosi
sle
ndn
rel
control
also
report
despit
limit
knowledg
origin
phenotyp
neutrophil
subpopul
presenc
circul
ldg
associ
gene
signatur
differ
patient
sampl
increasingli
consid
part
set
clinic
paramet
relev
evalu
diseas
activ
vascular
inflamm
respons
treatment
condit
system
vascul
sle
ra
juvenil
idiopath
arthriti
date
evid
true
mous
neutrophil
heterogen
mous
model
autoimmun
diseas
lack
human
multipl
heterogen
neutrophil
popul
display
either
proor
antitumor
function
identifi
within
circul
tumor
tissu
cancer
patient
well
tumorbear
mice
instanc
ldnspmnmdsc
box
figur
consist
found
blood
varieti
cancer
patient
nonsmal
cell
lung
cancer
nsclc
head
neck
cancer
hnc
hepatocellular
carcinoma
colorect
cancer
frequenc
cell
often
correl
diseas
sever
andor
respons
treatment
exampl
correl
welldescrib
heterogen
composit
ldnspmnmdsc
three
separ
ldnpmnmdsc
popul
advanc
hnc
urolog
cancer
patient
describ
base
spectra
differenti
express
eg
support
antitumor
cell
respons
isol
tumor
tissu
earlystag
lung
cancer
patient
mice
popul
immatur
neutrophil
display
immunosuppress
properti
report
blood
ldnspmnmdsc
spleen
bone
marrow
bm
tumor
tissu
tumorbear
mice
box
addit
two
subtyp
matur
circul
neutrophil
propos
present
tumorbear
mice
name
ndn
display
antitumor
properti
ldn
display
immunosuppress
protumor
properti
similarli
tan
display
antitumor
properti
eg
promot
antitumor
cell
respons
direct
tumor
cytotox
tan
matur
immatur
cell
display
protumor
properti
eg
immunosuppress
promot
tumor
cell
proliferationsurviv
promot
angiogenesi
tumor
cell
extravas
distant
metastat
tissu
also
report
within
tumor
tissu
trend
immunolog
high
degre
variabl
across
differ
individu
note
studi
report
immunosuppress
properti
typic
mediat
via
ro
releas
ldnspmnmdsc
differ
cancer
patient
well
condit
determin
specif
contribut
neutrophil
subpopul
tumor
progress
prognosi
line
previous
report
matur
neutrophil
gcsftreat
donor
matur
ldnspmnmdsc
popul
peripher
blood
hnc
urolog
cancer
patientsand
immatur
formsdisplay
higher
cellsuppress
activ
ex
vivo
subpopul
may
also
clinic
relev
high
number
pmnmdsc
pmnmdsc
subpopul
correl
advers
outcom
hnc
observ
highlight
import
character
phenotyp
function
properti
matur
immatur
neutrophil
furthermor
preliminari
cytometri
timeofflight
mass
spectrometri
cytof
analysi
data
use
peripher
blood
nsclc
cancer
patient
zg
fridlend
et
al
unpublish
could
support
util
possibl
indic
distinguish
neutrophil
subpopul
circul
cancer
patient
data
howev
remain
valid
unfortun
main
separ
ndn
ldn
report
far
base
densiti
neutrophil
thu
preclud
possibl
isol
better
character
specif
subpopul
although
densiti
gradient
per
se
ideal
identifi
neutrophil
subset
futur
clinic
test
set
current
constitut
import
method
studi
diseaserel
neutrophil
subpopul
recent
year
howev
sever
new
emerg
marker
distinct
popul
circul
neutrophil
describ
relat
clinic
set
differ
type
cancer
instanc
lectintyp
oxid
ldl
receptor
propos
put
marker
distinguish
suppress
popul
pmnmdsc
normal
neutrophil
blood
tissu
hnc
nsclc
cancer
patient
high
frequenc
circul
tumorloc
neutrophil
describ
hladr
low
pmnmdsc
instead
found
melanoma
patient
advanc
cancer
patient
present
high
frequenc
circul
cell
high
express
two
import
mediat
cell
suppress
neutrophil
suggest
cell
may
stronger
immunosuppress
phenotyp
group
also
describ
similar
phenotyp
circul
neutrophil
nsclc
anoth
studi
colorect
cancer
patient
receiv
form
cancer
therapi
express
increas
circul
neutrophil
rel
untreat
patient
healthi
donor
chronic
lymphocyt
leukemia
leukem
lymphocyt
promot
ex
vivo
differenti
neutrophil
immunosuppress
popul
character
high
dim
compar
neutrophil
expos
cell
condit
media
final
two
distinct
neutrophil
popul
high
low
neutrophil
present
blood
tumor
tissu
describ
patient
pancreat
ductal
adenocarcinoma
pdac
wherea
two
differ
circul
neutrophil
popul
found
base
differenti
express
immunoglobulinlik
transcript
high
lowin
nsclc
patient
marker
separ
cell
similar
morpholog
differ
express
profil
membran
protein
function
perhap
distinct
prognost
signific
inde
pdac
patient
high
neutrophil
shorter
overal
surviv
fewer
high
neutrophil
patient
increas
fraction
high
subset
shorter
median
surviv
patient
smaller
high
fraction
observ
regard
candid
marker
potenti
identif
neutrophil
subpopul
malign
possibl
diseas
although
attract
remain
valid
phenotyp
chang
cancerrel
circul
neutrophil
tumor
progress
affect
composit
infiltr
neutrophil
tumorsth
latter
gener
describ
tumorassoci
neutrophil
tan
figur
date
clear
whether
differ
trend
immunolog
neutrophil
popul
enter
tumor
whether
chang
occur
insid
tumor
microenviron
despit
fact
current
understand
phenotyp
mechan
infiltr
function
tan
still
limit
especi
human
heavi
infiltr
cell
within
tumor
microenviron
associ
dismal
prognosi
data
human
tan
mostli
assess
earli
cancer
materi
avail
studi
success
isol
human
tan
function
assay
report
cell
could
either
promot
inhibit
antitumor
cytotox
cell
respons
among
studi
worth
mention
small
popul
tan
express
marker
typic
associ
apc
includ
hladr
discov
lung
cancer
patient
uniqu
popul
neutrophil
term
hladr
apclik
hybrid
tan
report
stimul
support
antitumor
cell
respons
vitro
figur
recent
studi
identifi
popul
circul
ldn
tumorbear
mice
resembl
either
matur
immatur
cell
term
heterogen
composit
similarli
ldn
describ
blood
cancer
patient
howev
unlik
human
two
subtyp
circul
matur
neutrophil
tumorbear
mice
separ
within
ndn
ldn
layer
follow
densiti
gradient
centrifug
report
display
oppos
function
properti
specif
ndn
display
direct
tumor
cytotox
antitumor
properti
wherea
ldn
immunosuppress
tumorpermiss
popul
ex
vivo
vivo
figur
howev
mechan
lead
function
differ
matur
ndn
ldn
remain
unknown
major
popul
suppress
neutrophil
gener
describ
immatur
cell
consist
report
present
spleen
bm
tumor
tissu
tumorbear
mice
term
pmnmdsc
box
figur
biolog
featur
presum
role
diseas
comprehens
summar
recent
review
howev
note
relationship
cancerrel
neutrophil
includ
suppress
neutrophil
pmnmdsc
especi
mice
remain
somewhat
vagu
box
sever
studi
perform
tumorbear
mice
yet
valid
human
also
contribut
knowledg
neutrophil
within
tumor
microenviron
decad
ago
presenc
transform
growth
factor
tgf
demonstr
promot
differenti
tumorpromot
neutrophil
mice
refer
tan
wherea
blockad
result
antitumor
phenotyp
tan
figur
possibl
tan
proor
antitumor
phenotyp
may
sum
neutrophil
popul
properti
overal
tumorpromot
versu
cytotox
phenotyp
reflect
definit
dichotom
state
activ
versu
phenotyp
appear
result
complex
combin
gene
express
tilt
overal
phenotyp
balanc
may
inaccur
refer
singl
specif
gene
gene
altern
suggest
differ
tan
necessarili
due
two
uniqu
transcript
program
instead
repres
two
state
activ
word
tan
might
produc
mediat
differ
concentr
question
whether
tan
undergo
irrevers
polar
adopt
revers
activ
state
remain
unresolv
also
clear
cell
chang
cell
vice
versa
influenc
chang
tumor
microenviron
interest
studi
regard
recent
describ
nicotinamid
phosphoribosyltransferas
nampt
part
gcsf
signal
cascademight
involv
protumorigen
convers
neutrophil
insid
tumor
microenviron
affect
angiogenesi
studi
inhibit
nampt
signal
shown
decreas
express
proangiogen
factor
matrix
metalloproteinas
vegf
calciumbind
protein
tan
rel
control
treatment
thu
impair
develop
function
tumor
vasculatur
moreov
recent
work
suggest
glucoserestrict
tumor
microenviron
could
induc
metabol
adapt
oxid
neutrophil
maintain
intratumor
immunosuppress
subpopul
tan
addit
report
skew
neutrophil
phenotyp
insid
tumor
studi
exampl
influenc
microenviron
tan
phenotyp
mice
descript
differenti
mous
tan
subpopul
base
express
sever
marker
also
report
differ
mous
model
cancer
instanc
substanti
number
colon
tan
found
express
cytolyt
enzym
granzym
b
absent
neutrophil
spleen
peripher
blood
popul
tan
recruit
tumor
mesenchym
stromal
cell
msc
deem
respons
prometastat
effect
msc
mous
model
breast
cancer
final
mous
model
lung
adenocarcinoma
host
osteoclast
describ
promot
tumor
infiltr
siglecf
high
tan
tumorpermiss
properti
neutrophil
exhibit
higher
express
gene
involv
angiogenesi
tumor
prolifer
immunosuppress
well
display
higher
relat
activ
siglecf
low
tan
overal
studi
perform
mous
tumor
model
substanti
improv
knowledg
tan
howev
put
import
marker
descript
tan
phenotyp
remain
demonstr
patient
despit
grow
number
studi
describ
exist
special
neutrophil
subpopul
health
patholog
condit
unequivoc
evid
cell
actual
repres
true
novel
neutrophil
subset
lack
see
outstand
question
criteria
util
defin
neutrophil
subpopul
eg
cellsurfac
marker
buoyanc
matur
function
local
insuffici
definit
address
issu
therefor
essenti
current
avail
deep
phenotyp
nextgener
sequenc
approach
eg
mass
cytometri
singlecel
rna
use
perform
precis
character
phenotyp
transcript
profil
function
highli
purifi
matur
immatur
neutrophil
subpopul
identifi
homeostat
inflammatori
condit
experiment
approach
possibl
clarifi
specif
phenotyp
function
featur
defin
neutrophil
subpopul
eg
ldn
ndn
tan
name
relev
given
diseas
across
differ
diseasesinflammatori
condit
inde
like
approach
may
final
clarifi
whether
instanc
pmnmdsc
uniqu
separ
cell
popul
instead
subgroup
neutrophil
induc
suppress
activ
box
approach
help
field
gain
novel
insight
origin
neutrophil
subset
well
clarifi
whether
cell
deriv
commit
progenitor
whether
repres
differ
activ
state
singl
neutrophil
popul
sens
differ
microenviron
final
experiment
approach
might
potenti
allow
discoveri
standard
phenotyp
function
marker
uniqu
identifi
immunosuppressiveproinflammatori
protumoralantitumor
neutrophil
subset
might
exploit
put
prognost
therapeut
target
consensu
cd
marker
combin
present
human
neutrophil
work
intend
public
human
neutrophil
studi
subpopulationsactiv
state
requir
use
accept
baselin
gate
strategi
confirm
presenc
neutrophil
other
reproduc
result
baselin
refer
might
help
field
move
forward
effici
manner
given
sensit
neutrophil
perturb
manipul
ex
vivo
accept
standard
method
evalu
neutrophil
blood
sampl
minim
cellular
alter
agre
upon
util
clinic
research
studi
would
method
label
blood
neutrophil
subpopul
without
isolationmanipul
straightforward
path
standard
identif
clinic
relev
neutrophil
subpopul
patient
develop
standard
protocol
isol
pure
popul
put
neutrophil
subpopul
util
highthroughput
technolog
definit
address
whether
repres
bona
fide
subset
exampl
express
specif
master
transcript
factor
differenti
specif
commit
precursor
vitro
defin
consensu
function
marker
unequivoc
defin
proinflammatori
antiinflammatori
neutrophil
subpopul
neutrophil
subpopul
use
diagnost
prognost
marker
diseasespecif
context
identifi
therapi
elev
specif
neutrophil
subpopul
improv
diseas
outcom
